Antimicrobial resistance at a crossroads: the cost of inaction. Craig M, Jernigan D, Laserson K, McBride S, et al. Lancet 2024 Sep 9:S0140-6736(24)01705-7. doi: 10.1016/S0140-6736(24)01705.

Read + Share

Amedeo Smart

Independent Medical Education

Craig M, Jernigan D, Laserson K, McBride S, et al. Antimicrobial resistance at a crossroads: the cost of inaction. Lancet 2024 Sep 9:S0140-6736(24)01705-7. doi: 10.1016/S0140-6736(24)01705.
PMID: 39265589